Previous Close | 0.0420 |
Open | 0.0360 |
Bid | 0.0000 x 800 |
Ask | 0.0000 x 1100 |
Day's Range | 0.0350 - 0.0375 |
52 Week Range | 0.0210 - 0.2760 |
Volume | |
Avg. Volume | 110,948 |
Market Cap | 3.503M |
Beta (5Y Monthly) | 1.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2000 |
Earnings Date | Apr 18, 2024 - Apr 21, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
COLUMBUS, Ohio, January 27, 2024--Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
DUBLIN, Ohio, December 01, 2023--Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
DUBLIN, Ohio, October 06, 2023--Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock